Undergrad: University of Rochester
Residency: Residency in Emergency Medicine Bellevue NYU
Academic Interests: SICKLE CELL DISEASE, proving to hematologists that EM docs are capable of doing research to elucidate the biological basis of disease in addition to research about emergencies.
Personal Interests: Skiing (former competition mogul skier), Guitar (heavy metal, blues, rock), Food food and more food, Wine to go with the food, Whisky from Scotland (there is no 'e' in Whisky)
Dr. Jeffrey Glassberg is tenured Professor of Emergency Medicine and Medicine (Hematology and Medical Oncology) at the Icahn Sinai School of Medicine. He obtained his MD and a Masters’ degree in clinical research at Washington University in St. Louis School of Medicine in 2006. Dr. Glassberg completed his emergency medicine residency at NYU/Bellevue in 2010, followed by a research fellowship at Mount Sinai in July of 2012. Currently, Dr. Glassberg is funded by the National Heart Lung and Blood Institute by a K23 career development award and also holds an appointment at Rockefeller University as a visiting scientist.
Dr. Glassberg has become a leader in promoting evidence based strategies for the acute management of Sickle Cell Disease. He has several research focuses within Sickle Cell including pulmonary complications of Sickle Cell Disease, novel biomarkers for vaso-occlusive crises, and novel agents for the prevention and treatment of vaso-occlusion. In addition to practicing as an attending in the ED, Dr. Glassberg also sees patients in Sickle Cell clinic and serves as the primary physician for many patients with Sickle Cell disease who are at Mount Sinai. He is also active regionally and nationally as a member of the Queens Sickle Cell Advocacy Network, the New York Sickle Cell Advisory Council and the Sickle Cell Disease Association of America.